Submitted by Anonymous (not verified) on 11 June 2026 - 14:32
Human medicines European public assessment report (EPAR): Qtern, saxagliptin,dapagliflozin, Date of authorisation: 15/07/2016, Revision: 16, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Qtern, saxagliptin,dapagliflozin, Date of authorisation: 15/07/2016, Revision: 16, Status: Authorised